Solara Active Pharma Sciences Share Price
636.65+6.80 (+1.08%)
-5.79% past 1 Year
Solara Active Pharma Sciences is a young dynamic entrepreneurial and customer oriented API manufacturer. The company has a legacy of over three decades and traces its origins to the API
Corporate filings & documents
Announcements
Solara Active Pharma Sciences Limited has informed the exchange about intimation in connection with the receipt of Rectification Order
1 week agoSolara Active Pharma Sciences Limited has informed the exchange about intimation in connection with the receipt of Rectification Order
1 week agoNewspaper publication regarding the completion of dispatch of 9th AGM Notice and Annual report
1 week agoNewspaper publication regarding the completion of dispatch of 9th AGM Notice and Annual report
1 week agoBusiness Responsibility and Sustainability Reporting for the financial year 2025-26.
1 week agoBusiness Responsibility and Sustainability Reporting for the financial year 2025-26.
1 week agoAnnual Report for the financial year ended March 31 2026
1 week agoAnnual Report for the financial year ended March 31 2026
1 week agoSolara Active Pharma Sciences Limited has informed the exchange about the dispatch of Notice of Ninth Annual General Meeting (AGM) of the Company scheduled to be held on Friday September 18 2026
1 week agoSolara Active Pharma Sciences Limited has informed the exchange about the dispatch of Notice of Ninth Annual General Meeting (AGM) of the Company scheduled to be held on Friday September 18 2026
1 week agoSolara Active Pharma Sciences Limited has informed the stock exchange regarding the Newspaper publication with respect to the Ninth Annual General Meeting.
1 week agoSolara Active Pharma Sciences Limited has informed the stock exchange regarding the Newspaper publication with respect to the Ninth Annual General Meeting.
1 week agoConversion of Partly paid-up Rights Equity Shares into fully paid-up Equity shares in relation to the rights issue by the Company upon receipt of Call Monies as applicable.
2 weeks agoConversion of Partly paid-up Rights Equity Shares into fully paid-up Equity shares in relation to the rights issue by the Company upon receipt of Call Monies as applicable.
2 weeks agoSolara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 equity shares pursuant to exercise of ESOP options
2 weeks agoSolara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 equity shares pursuant to exercise of ESOP options
2 weeks agoSolara Active Pharma Sciences Limited has informed the exchange regarding the update with respect to our intimation dated July 23 2026 regarding appointment of Chief Information Officer ("CIO") and Senior Management Personnel ("SMP")
3 weeks agoSolara Active Pharma Sciences Limited has informed the exchange regarding the update with respect to our intimation dated July 23 2026 regarding appointment of Chief Information Officer ("CIO") and Senior Management Personnel ("SMP")
3 weeks agoTranscript of Earnings Conference call pertaining to financial results of the Company for the quarter ended June 30 2026
1 month agoTranscript of Earnings Conference call pertaining to financial results of the Company for the quarter ended June 30 2026
1 month agoSolara Active Pharma Sciences Limited has informed the exchange about the copy of the Newspaper publication providing extract of the unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026
1 month agoSolara Active Pharma Sciences Limited has informed the exchange about the copy of the Newspaper publication providing extract of the unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026
1 month agoSolara Active Pharma Sciences Limited has informed the exchange regarding submission of Machine Readable copy of Financial results for the quarter ended June 30 2026
1 month agoSolara Active Pharma Sciences Limited has informed the exchange regarding submission of Machine Readable copy of Financial results for the quarter ended June 30 2026
1 month agoSolara Active Pharma Sciences Limited has informed the exchange about the Audio Recording of the Q1 FY 27 Earnings call held on July 23 2026 at 16.00 IST
1 month agoSolara Active Pharma Sciences Limited has informed the exchange about the Audio Recording of the Q1 FY 27 Earnings call held on July 23 2026 at 16.00 IST
1 month agoMonitoring Agency Report for the quarter ended June 30 2026
1 month agoMonitoring Agency Report for the quarter ended June 30 2026
1 month agoSolara Active Pharma Sciences Limited has informed the exchange that there is no Deviation and Variation of funds raised through Rights Issue for the quarter ended June 30 2026
1 month agoSolara Active Pharma Sciences Limited has informed the exchange that there is no Deviation and Variation of funds raised through Rights Issue for the quarter ended June 30 2026
1 month agoSolara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 Equity Shares pursuant to exercise of ESOP options.
1 month agoSolara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 Equity Shares pursuant to exercise of ESOP options.
1 month agoSolara Active Pharma Sciences Limited has informed the exchange regarding the appointment of Mr. Ajit Manocha as Chief Information Officer (CIO) and designated him as Senior Management Personnel (SMP) withe effect from August 10 2026.
1 month agoSolara Active Pharma Sciences Limited has informed the exchange regarding the appointment of Mr. Ajit Manocha as Chief Information Officer (CIO) and designated him as Senior Management Personnel (SMP) withe effect from August 10 2026.
1 month agoSolara Active Pharma Sciences Limited has informed the exchange regarding the Press Release dated July 23 2026 titled- Solara reports strong Q127 Base business performance with continued Growth and Profitability.
1 month agoSolara Active Pharma Sciences Limited has informed the exchange regarding the Press Release dated July 23 2026 titled - Solara reports Strong Q127 Base business performance with Continued Growth and Profitability
1 month agoSolara Active Pharma Sciences Limited has informed the exchange regarding the Press Release dated July 23 2026 titled - Solara reports Strong Q127 Base business performance with Continued Growth and Profitability
1 month agoSolara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated financial results for the quarter ended June 30 2026 along with the Limited Review Report for the said period.
1 month agoSolara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated financial results for the quarter ended June 30 2026 along with the Limited Review Report for the said period.
1 month agoSolara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2026 along with the Limited Review Report for the said period.
1 month agoSolara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2026 along with the Limited Review Report for the said period.
1 month agoSolara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Thursday July 23 2026 at 4.00 PM IST to discuss the Companys unaudited financial results for the quarter ended June 30 2026.
1 month agoSolara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Thursday July 23 2026 at 4.00 PM IST to discuss the Companys unaudited financial results for the quarter ended June 30 2026.
1 month agoSolara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 inter alia to consider and approve the unaudited Standalone and Consolidated financial results of the Company for the quarter ended June 30 2026
1 month agoSolara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 inter alia to consider and approve the unaudited Standalone and Consolidated financial results of the Company for the quarter ended June 30 2026
1 month agoCopy of newspaper publication with respect to Final Reminder cum Forfeiture Notice for payment of Call money to partly paid equity shareholders
1 month agoCopy of newspaper publication with respect to Final Reminder cum Forfeiture Notice for payment of Call money to partly paid equity shareholders
1 month agoThe Company has informed the exchange about the Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026
1 month agoThe Company has informed the exchange about the Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026
1 month agoSolara Active Pharma Sciences Limited has informed the exchange about the approval of the Reminder - cum- Forfeiture Notice by the Rights Issue Committee members to be issued to the partly paid shareholders.
2 months agoAnnual reports
Concalls & investor presentations
Jul 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Nov 2025
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
ConcallPresentation
Jul 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
Jan 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
Apr 2022
Corporate Actions
Date
Type
Details
2024-05-15
Rights
1:3;375.0 (Rights ratio;Offer price)
2021-08-18
Dividend
3.0
2020-11-19
Dividend
4.0
2020-07-28
Dividend
2.0
2019-08-06
Dividend
5.0
Company details
Registered office
9th Floor, ‘ Cyber One’, Unit No. 902 Plot No. 4 & 6, Sector 30 A Vashi Navi Mumbai Maharashtra PIN: 400703 Tel No: 022 2789 2924 / 2789 3199 / 20870033 Fax No: 022 2789 2942 Email: [email protected] Internet: www.solara.co.in
Registrars
Subramanian Buildings No 1 , Club House Road,,Chennai Subramanian Buildings No 1 Club House Road NULL PIN: Tel No: 044-28460390/28460394 Fax No: 044-28460129 Email: NULL
Management
Pooja Jaya Kumar, Company Secretary & Compliance Officer
Ramakrishnan Rajagopal, Non Executive Independent Director
Kausalya Santhanam, Non Executive Independent Director
Rajendra Kumar Srivastava, Non Executive Independent Director
Rajiv Vijay Nabar, Non Executive Independent Director
Sandeep Rao, Managing Director & Chief Executive Officer
Mohanraj Sanjeevi, Whole Time Director & Chief Human Resources Officer
Arun Kumar Pillai, Non Executive Director
Manish Gupta, Non Executive Director
Details
BSE 541540
NSE SOLARA
ISIN INE624Z01016